Xin Fang Li

Amministratore Delegato presso MabPlex International Co., Ltd.

57 anni

Health Technology

Consumer Services

Profilo

Xin Fang Li is currently the CEO, General Manager & Director at MabPlex International Co., Ltd.
Prior to this, they earned a doctorate degree from Peking University in 1997.

Posizioni attive di Xin Fang Li

Società	Posizione	Inizio
MabPlex International Co., Ltd. MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China.	Amministratore Delegato	01/01/2022

Tutte le posizioni attive di Xin Fang Li

Formazione di Xin Fang Li

Peking University

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Xin Fang Li

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
MabPlex International Co., Ltd. MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China.	Health Technology